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The expanding list of antiretroviral drugs, the increasing
possibilities in therapy of HCV and other co-infections
represent an attractive setting for individualized pre-
scription. However, there has been considerable hype,
and limited impact of pharmacogenetics in care.
The development of pharmacogenetic tools would be
of interest considering the complexity of treatment, the
cost, and the expectation of long-term exposure. It would
also be desirable given the possibility of serious toxicity,
but also treatment intolerance, cumulative toxicity or the
unfavorable interaction of drugs and aging, metabolic,
cardiovascular and bone disease processes.
This presentation will review available tests, the posi-
tion of agencies on the inclusion of pharmacogenetic
information in labels, and a perspective on developments
in genomic medicine.
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